Damage to the microvasculature occurs commonly in autoimmune diseases affecting the skin. There has been little investigation of immune mechanisms other than immune complex deposition as a major cause of microvascular damage. We have investigated the potential of antibody-dependent cellular cytotoxicity (ADCC) to cause vascular destruction in an in vitro model consisting of human dermal microvascular endothelial cells to which were added antibody and leukocytes. Severe damage was induced by D amage to the dermal microvasculature is a prominent feature of human autoimmune diseases, such as systemic lupus erythematosus (SLE) and vasculitis, that commonly affect the skin. Immune complex deposition with complement activation followed by phagocyte chemotaxis and activation is believed to be the mechanism by which these lesions are caused [1, 2] .
antibody and lymphocytes. Monocytes or neutrophils were not able to mediate cytotoxicity although activated neutrophils caused endothelial detachment. The cytotoxic cells were OKT3 -, Leu 11 + and were identified as K cells. ADCC was not inhibited by human serum or aggregated IgG. These results imply that ADCC may have a role in causing the vascular destruction observed in some human autoimmune skin diseases. J Inllest D ermatol 87:519-523,
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We studied the potential of ADCC to cause dermal microvascular destruction by constructing an in vitro model consisting of tissue cultures of human dermal microvascular e.ndothelial cells and peripheral blood cells. It was found that ADCC induced severe endothelial injury, and the investigation of this cytotoxic system forms the subject of this report.
MA TERIALS AND METHODS
Unless otherwise stated all tissue culture media and additives w~re obtained from Flow Laboratories (Ayrshire, Scotland) , tissue c' ulture and other disposables from Corning, and analytical gr~de chemicals and other compounds from the Sigma Chemical Company or Ajax Chemicals (Sydney, Australia) .
Peripheral Blood Leukocytes Blood was collected from healthy laboratory personnel and anticoagulated with 0.5% sodium citrate . Mononuclear cells were isolated on a Ficoll-Paque discontinuollS density gradient (Pharmacia Fine Chemicals) . Neutrophils were separated from the erythrocyte pellet by resuspending it in 3% dextran followed by sedimentation at 1 g and 37°C for 20 min. The neutrophil-rich supernatant was freed of erythrocytes by two 20-s cycles of hypotonic lysis with phosphate-buffered saline (PBS) diluted 1:9 in water. Both cell preparations were typically more than 98% viable as assessed by try pan blue dye exclusion and less than 5% contaminated by other cell types. Cells were washed twice with Hanks ' balanced salt solution (HBSS) without calcium or magnesium and suspended for use in M19?H (Medium 199 with 25 mM HEPES buffer) .
Lymphocyte and Monocyte Separation by Centrifugal Elutriation Mononuclear cells were separated into lymphocyte and monocyte populations by centrifugal elutriation using a Beckman JE-6B e1utriation system and rotor [9] . The cells were collected in 5 fractions; fractions 2 and 4 contained cells enriched for lymphocytes and monocytes, respectively . Differential cell counts were performed on cytocentrifuged preparations after air drying and Giemsa staining.
Monoclonal Antibody Staining, Flow Cytometry, and Sorting In order to facilitate flow cytometry, the mononuclear cell preparation was depleted of platelets , monocytes, and B lymphocytes by adherence to a nylon wool column [10] . The resultant population of lymphocytes was stained with fluorescein-conjugated monoclonal antibodies OKT3 (Ortho Diagnostics, New 0022-202X/86/$03.S0 Copyright © 1986 by The Society for Investigative Dermatology, Inc.
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Jersey, U .S. A.) or Leu 11 (Becton Dickinson, Califo rnia, U .S. A.) fo r 20 min at 4°C following which they were was hed tw ice, res uspended in PBS, and kept at 4°C until used . Cell sorting w as do ne in a Coulter Epics V fl ow cyto meter equipped w ith a Spectra phys ics 164-05 laser o perated at 488 nm and an o utput of 400 m W . Cells were gated for sorting on the basis o f flu o rescence and the forward angle light scatter signal.
Serum and Culture Medium Blood w as collected and pooled fro m several healthy laboratory personnel into 50-ml plas tic centrifuge tubes, clotted at 37°C for 1 h, and the clo t retracted at 4°C fo r 1 h. The cells were rem o ved by centrifuga ti on and the serum stored at -20°C until used . Serum utilized in an attempt to inhibit ADCC was isolated immediately befo re use and was not frozen. C ulture m edium consisted of 50% hum an serum in Medium 199 containing van com ycin 100 m g/li ter, amphotericin 2.5 mglliter, genta m icin 50 m g/liter, and H E PE S bu ffer 25 mM.
Aggregated IgG Im munoglobulin G w as hea t agg regated [11] , separated fro m residual m ono m eri c IgG ' by preci pi tation with 3.5% polyeth ylene glycol [1 2] , and had its pro tein concentration determined before storage at -20°C. The agg regates were tes ted fo r immune complex activi ty by their capacity to bind radiolabeled Cl q [1 3] . Aggregated IgG at concentrations of125 m g/liter and 12.5 m g/liter ca used C 1 q binding, respectively , o f 40% and 25% (normal sera r ange fo r binding, 0-1 2% ).
C ell Activators Boiled zymosan was opsonized in fres h human serum at a concentra ti on o f 10 g/li ter fo r 1 h at 37°C in' a shaking water ba th. T he zym osan w as was hed tw ice in PBS, resuspended in M1 99H, and used at a fin al concentratio n of 5 g/liter. Pho rbolmyristate acetate (PMA) w as dissolved in DMSO at 1 g/li te r, diluted in M 199H , and used at a fin al concentration of 10-7 M. O psonized zymosan and P MA we re con fi rmed as acti ve in the concentrations used by their ca pacity to induce a chemiluminescent response in neutrophils and m onocytes.
Antibody for Inducing ADCC T he antibody used in these studies was a rabbit IgG antihuman B 2 -microglobulin (Dakopatts, Glos trup, Denmark). It was shown to bind to cultured endothelial cells by positive indirect immuno flu orescence. T he antibody w as used at a dilution of 1:100 unless o therwise stated . N ormal rabbit seru m was used as a control for the antibody.
Endothelial C ells Endo thelial cells w ere extracted and grown fro m human neonatal fores kins as described [14] . Endotheli al identity w as confirmed by positive immunoflu o rescence for Factor VIII antigen, by the typical m orphology o f confluent cultu res and the presence of Weibel-Palade bodies.
Cytot o x icity A ssay Endothelial cytotoxicity was assessed in 96-well flat-botto m tissue culture plates. T he wells w ere precoated w ith 50 f.l-l of fi bro nectin (10 mg/liter) w hi ch was as pirated after 10 min. Endo thelial cells (1 0,000-20,000) w ere added to each well in 100 f.l-l of cultu re m edium conta ining 2 X 10-3 gigaBecquerels of N a 5 1 C r04 (A mersham , U .K. ). G rea ter than 85% of the cells would attach to the culture surface overnight. T he next day attached cell s were gentl y was hed 5 times w ith HBSS-BS A and left fo r 2 h in fres h culture m edium . At the end o f this time the cells were washed twice w ith H BSS-BS A and the effector cells added in a total volume of 150 J.Ll o f M1 99H . An effecto r to targe t (E:T ) cell ra tio of 50: 1 was used unless otherwise stated . In experiments where antibody w as used in conjuncti on w ith effector cells it was added to the target cells in M1 99H and incubated fo r 20 mi n at room temperature, then aspirated and the effector cells added .
Effector cells were usually incubated wi th the endo thelial targets fo r 4 h at 37°C. At the end of this peri od the contents of each well were as pirated and pooled w ith 2 further gentle was hings of 100 f.l-l each (tube a). T hese pooled washin gs were centrifuged at 200 g for 10 min and the top half of the supernatant removed fro m tube a and transferred to ano ther tube (tube b) . T he cells rem aining in the mjcrowells w ere rem oved w ith 100 f.l-l
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of 0.05% try psin and 0.02% EDTA and transferred to a third tube (tube c). It was fo und that try psin-E DT A rem oved sig nifica ntl y m ore radioactivity fro m the culture wells than either d etergent trea tment with 0.1 % T riton X-lOO or freeze-thawing. The volumes in the tubes were equalized and the tubes counted in a Packard PRiAS ga mma counter fo r 1 min . Da ta were expressed as percent C r release calculated as 200 x b/ (a + b + c) and percent detached cells calcul ated as 100 x (a -b) / (a + b + c). All experimental conditions we re performed in triplica te an d the res ults reported as the m ea n o f these 3 rea din gs. If 2 x SE was g rea ter than 1 % it w as also reported all d represented in fi g ures by erro r bars.
RE SULTS
Antibody-Dependent Cellular Cytotoxicity Induce d b y Mononuclear Cells The effect of adding a m on onuclear cell prepara tion to the endo thelial cell s is shown in Table I . In the abse nce of antibody, m ononuclea r cells w ere able to induce only a sm all increase in C r release. Antibody pretrea tment of endothelial cells led to m arked m ono nuclea r cell-mediated damage. The endothelial cell dam age w as antibod y-specific as substituting no rmal rabbit se rum fo r antibody was not associated w ith cytotoxicity (res ults no t shown) . There w as also so m e eviden ce of endothelial detachment acco mpanying the ADCC but it w as much less than the actu al C r release.
T he param eters of the cyto toxic system were inves tigated b y following the time course of the dam age and titrating the antibo d y and the effecto r cells. T he res ults are shown in Fi gs 1-3.
Mononuclear Cell-Induced ADCC Is Due to Lymphocytes A m ononuclea r cell preparati on w as separated by centrifugal elutriation into populati ons enriched for n1.onocytes (monocytes 75%, lymphocytes 15%, neutrophils 3%, unidentified cells 7% ) and lymphocytes (lymphocytes 83%, m o nocy tes 17% ). T hese preparati ons as well as neutro phils w ere tes ted fo r their ability to indu ce AD CC over a range of E: T cell ratios. T he res ults are shown in Fig 4. C hro mium release induced by the lymphocytes very closely resembled C r release indu ced by the whole m o n onuclea r cell prepara ti on except that the ly m phocytes were m ore poten t at the lowest E:T cell ratio . M onocytes did not ca use an y C r release except at the larges t E:T cell ra tio , probably due to the 15% lymphocytes contaminating the m onocyte preparation .
Antibody-Dependent Cellular Toxicity of Lymphocyte Subpopulations Further attempts were m ade to isolate the cell populati on responsible for the ADCC by identifyin g subpopulati ons of lymphocytes w ith m onoclo nal antibodies , separating positively and negati vely stained lymphocytes b y fl ow cytom etry , and cell sortin g and using them as effector cells.
The results of tes ting O KT3-positive and -negati ve staining ly mphocytes fo r AD CC are shown in T able II. C hro mium release w as largely associated with the OKT3-negative populati on , su g- ges ting that the cell m ediatin g the ADCC was no t a T cell . Controls demonstrated that cells stai ned with antibody and passed through the flow cytometer retained the capacity to mediate ADCC. Res ults not sho wn indica te that staining lymphocytes with OKT3 was not able to substitu te for the antiendothelial antibod y in inducing ADCC. The resu lts of testing Leu ll -positive and -negative stai nin g lymph ocytes for ADCC are shown in Table III . T he ADCC activi ty was entirely associated w ith the Leu ll-positive fraction. The controls were the sa m e as for OKT3.
Failure to Inhibit ADCC with Serum or Aggregated IgG Increasing concentrations of human serum or hea t-aggrega ted fgG were added with mononuclea r cells to antibody-treated endothelial cells to determine w hether they could inhibit ADCC. T he anti body was used at a suboptimal dilution of 1:10,000 in order to fac ilitate any inhibitory influence of the add itives. T he results are s hown in Fig 5 and demonstrate that neither reagent was inhibitory . Res ults not sho wn demonstrate that 75% of hum an serum or 100 ILg/ ml of aggregated IgG had no effect on C r release from antibod y-trea ted endo thelial cells in the absence of m ononuclear cells. Failure of Neutrophils to Induce Cytotoxicity Attempts were m ade to induce endothelial damage with zy m osan-activated neutrophils in the sa m e way as had been done w ith mononuclear cells. N eutro phils we re not able to ca use any in crease in Cr release either directl y or b y ADCC (res ul ts not shown). As it has been suggested that zy m osan m ay inhibit rather than induce phagocyte-m ediated endothelial damage [15) , the experi m ent was repeated , w ith the nonparticulate stimulus PMA used as the phagocyti c activator; however the res ults were the sa m e. Activated neut rop hils were, however, able to indu ce detachment of endothelial cells from the culture surface, increasing from 1 % fo r untrea ted end othelium to 8( ± 2)% for end othelium exposed to zy m osan-acti va ted neutrophils. Antibody did not affect these results. M edium 199 contain s amino acids, so m e of w hich are capable of scaveng ing the oxidants that mediate neutrop hil cytotoxicity. H owever repeated experiments performed llsing HBSS as an alternative to M 199H fa iled to demonstrate neutrophilm ediated endothelial cytotoxicity.
DISCUS SIO N
Endothelial cells derived fro m large blood vessels such as the umbilical vei n are easily cultured and have been very w idely used to stud y vascular physiology and pathology. However the en- bLy mphocytes passed through the flow cy tometer but otherwise untreated. ' Lymphocytes sta ined with antibody to OKT3 and passed through the flow cytometer but collected in one sample without any attempt to separate positive-from ne¥.ative-staining cells.
Lymphocy tes sorted on the basis of positive staining for OKT3. ' Lymphocytes sorted on the basis of negative staining for OKT3.
dothelium is a heterogeneous tissue with major differences between endothelium of large and small blood vessels [16, 17] . Huan microvascular endothelial cells were used in this study because mflammatory and immune vascular damage occurs far more commonly in the microvasculature than in large vessels. There is also evidence that suggests that important organ-specific differences may exist between different microvascular beds [18, 19] . Therefore endothelial cells derived from the dermis were utilized as the skin is a common site for immune vascular damage . . ADCC was first described by Moller in 1965 [20] and since that tim~ has been shown to be capable of being mediated by several different effector cell types . For a cell to function in ADCC it is nece.ssary that it possess cytotoxic capacity and an Fc receptor for bmdmg to the antibody-coated target cell. Of the cells in the peripheral blood these requirements are fulfilled by monocytes, polymorphonuclear leukocytes, and killer (K) cell s [21] . However the cells mediating ADCC in this experimental system were restricted to the subpopulation of lymphocytes known as K cells [22] , a lineage oflymphocytes distinct from T and B cells [23, 24] . It has been shown that ADCC is capable of killing a large range of target cells [25] including keratinocytes [26] and umbilical vein endothelial cells [27] , although cytotoxicity for microvascular endothelial cells has not previously been demonstrated.
The antibody Leu 11 was used to separate the lymphocytes beCause it identifies all the lymphocytes in the peripheral blood that have K cell activity and does not identify T cells or B cells [28, 29] . Leu 11 inhibited the endothelial cytotoxicity observed by 20%, possibly because it interfered with the binding of the Fc reGeptor on the K cell to the antibody on the endothelial cell . As expected, all the ADCC was found in the Leu ll-positive population and none at all in the Leu 11-negative population. OKT3 was used to separate T cells [30] and most of the ADCC was ; Lymphocytes were used at an effector to target cell ratio of 15:1. , Lymphocytes passed through the flow cytometer but otherwise untreated . Lymphocytes stained with antibody to Leu 11 and passed through the flow cytometer but coll~cted in one sample without any attempt to separate positivefrom ncga uvc-stallung cells.
' Lymphocytes sorted on the basis of positive staining for Leu 11. 'Lymphocytes sorted on the basis of negative staining for Leu 11. identified in the OKT3~n.egative population. It was not surprising that there was some killing With the OKT3-positive population as ~ proportion of immature K cells are known to express the T3 antigen [31] , reactivity diminishing as the cells develop. Rabbit anti-f32-microglobulin antibody was used to induce the ADCC. Rabbit antibody was used beca use human antibodies with reactivity for all human endothelial cells are not available. Rabbit immunoglobulin has been w idely used to investigate antibody interactions with human immune cell s and has been shown to occupy. the same bindin.g site as hu.man immunoglobulin [32] .
In spite of the extensIve deSCrIptIons of ADCC in vitro there is only relatively limited information suggesting a role for ADCC as a cause of in vivo human pathology [7 ,8,27,33] . The demonstration of ADCC against endothelial cells in vitro raises questions as to the significance of this phenomenon as a cause of human vascular Immunopathology. Binding of the Fc region of an antlbod'y to the Fcreceptor on a cytotoxic cell may be competitively mhlblted by flllld phase Immune complexes, and the OCCllrrence of this phenomenon has been used to argue against the relevance o.f ADC.C to human patholo~y [34, 35) . However it was not posSible to mhlblt the ADCC With increasing concentrations of human serum or of aggregated IgG even using a limiting concentration of endothelial antibody. Thus for at least some concentrations of tarl?et ~e ll .antibody and immun e complex, ADCC may be operatIve 111 VIVO .
Further evidence for the possibl e involvement of lymphocytemediated ADCC in human pathology has come from our recent (unpubli.shed)o studies: Ly.mpl~ocytes with the K phenotype are present m 35 Yo of skill biopSies from patients with progressive systemI.c sclerosis and in addition 19% of these patients have a clrculatmg antibody th at will nl.ediate ADCC against human dermal microvascular endothelial cells. 
